RxDoctor Payments Data

Craig Barrow, MD

Foot and Ankle Surgery · Spokane, WANPI 1265539944

Payments from drug & device makers

$995in general payments, 2019–2025

Across 28 payments — averaging $35.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$642
  • Smith+Nephew$178
  • Merck$34
  • Sawtooth Surgical Solutions Inc$33
  • Johnson & Johnson$24
  • Polynovo North America LLC$24
  • plus $60 from 3 others

What the payments were for

  • Food & beverage$80281%
  • Gifts$19319%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)15$642
Smith+Nephew4$178
Merck2$34
Sawtooth Surgical Solutions Inc2$33
Johnson & Johnson1$24
Polynovo North America LLC1$24
Avanos Medical1$21
Bioventus LLC1$20
Summit Surgical Corp.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$995 in reported general payments places this provider in the 40th percentile of 203 foot and ankle surgery providers in Washington.

See all foot and ankle surgery providers in Washington

Medicare billing

Part B allowed, 2024
$93,906
Medicare patients
214
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron72$1,202
Oxycodone Hcl103$751
Tizanidine Hcl147$620
Hydroxyzine Hcl67$565
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$526
Cephalexin24$404
Gabapentin19$213
Clindamycin Hcl14$210
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim37$202
Hydromorphone Hcl15$92

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →